Hong Yan et al. showed that only male CRC patients with the KRAS mutation had several altered metabolic pathways that suppress ferroptosis (a non-apoptotic mode of cell death), including glutathione biosynthesis, transsulfuration activity, and methionine metabolism [41]. The gene discussed is KRAS; the disease is colorectal carcinoma.